Results 61 to 70 of about 2,517,915 (228)

LSD degrades hippocampal spatial representations and suppresses hippocampal-visual cortical interactions

open access: yesCell Reports, 2021
Summary: Lysergic acid diethylamide (LSD) produces hallucinations, which are perceptions uncoupled from the external environment. How LSD alters neuronal activities in vivo that underlie abnormal perceptions is unknown.
Carli Domenico   +3 more
doaj   +1 more source

Possible role of biochemiluminescent photons for lysergic acid diethylamide (LSD)-induced phosphenes and visual hallucinations [PDF]

open access: yes, 2017
Today, there is an increased interest in research on lysergic acid diethylamide (LSD) because it may offer new opportunities in psychotherapy under controlled settings.
Bókkon, István   +5 more
core   +1 more source

Effect of lysergic acid diethylamide and its brom analogue on arterial hypertension in the rat

open access: yes, 1961
Subcutaneous administration of d-lysergic acid diethylamide (LSD) or 2-brom- d-lysergic acid diethylamide (BOL) markedly lowered the blood pressure of renal hypertensive rats.
George H. Fried   +3 more
core   +1 more source

Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD)

open access: yesDrug Testing and Analysis, 2020
Lysergic acid diethylamide (LSD) is a prototypical serotonergic psychedelic drug and the subject of many clinical investigations. In recent years, a range of lysergamides has emerged with the production of some being inspired by the existing scientific ...
Simon D. Brandt   +10 more
semanticscholar   +1 more source

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers

open access: yesPsychopharmacology, 2019
Research has shown that psychedelics, such as lysergic acid diethylamide (LSD), have profound anti-inflammatory properties mediated by 5-HT2A receptor signaling, supporting their evaluation as a therapeutic for neuroinflammation associated with ...
Neiloufar Family   +8 more
semanticscholar   +1 more source

Lysergic acid diethylamide (LSD-25): IX. Effect on snails

open access: yes, 1955
"Certain species of snails are at least as sensitive to lysergic acid diethylamide (LSD-25) as are the Siamese fighting fish (Betta splendens). Ambularia cuprina (Mystery Snail) responds to LSD-25 with a typical, persistent, disorganized movement of the ...
Harold A. Abramson   +3 more
core   +1 more source

Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs

open access: yesVeterinary and Animal Science, 2023
Pets can have accidental, intentional, or malicious exposure to illicit drugs. It is a growing concern over the last decade because there is an increase in usage of illicit drugs in humans and diagnosis is difficult.
Ena Oster   +6 more
doaj   +1 more source

Lysergic Acid Diethylamide (LSD) and mystical experiences

open access: yes, 2016
Lysergic acid diethylamide (LSD) is the best-known drug of a subtype of hallucinogens, commonly referred to as psychedelics. LSD is by far the most potent psychedelic and one of the most potent psychoactive substances ever discovered.
Lyvers, Michael, Michael Lyvers
core   +1 more source

Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain

open access: yesJournal of Fungi, 2022
Mushrooms have been used as traditional medicine for millennia, fungi are the main natural source of psychedelic compounds. There is now increasing interest in using fungal active compounds such as psychedelics for alleviating symptoms of mental health ...
Elaine Meade   +3 more
doaj   +1 more source

Exploring new avenues: Psychedelic‐assisted therapy for young people

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy